Income Statement

v3.8.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Revenues:        
Grants $ 0 $ 0 $ 0 $ 148,054
Total revenues 0 0 0 148,054
Operating costs and expenses:        
Research and development 1,017,061 1,671,181 6,168,125 4,967,695
General and administrative 1,831,629 2,420,516 7,513,621 7,001,521
Total operating costs and expenses 2,848,690 4,091,697 13,681,746 11,969,216
Loss from operations (2,848,690) (4,091,697) (13,681,746) (11,821,162)
Interest and other expense (231,471) (266,051) (743,137) (729,331)
Net loss (3,080,161) (4,357,748) (14,424,883) (12,550,493)
Deemed dividend on inducement shares 0 0 (5,220,000) 0
Deemed dividend on incentive shares (3,120,000) 0 (3,120,000) 0
Deemed dividend on warrant reprice 0 0 (19,413) 0
Net loss allocable to common stockholders $ (6,200,161) $ (4,357,748) $ (22,784,296) $ (12,550,493)
Basic and diluted net loss per share $ (2.68) $ (0.86) $ (.54) $ (2.87)
Shares used to calculate basic and diluted net loss per share 11,490,839 5,041,408 8,504,076 4,374,801

Source